4//SEC Filing
Atkisson Erik 4
Accession 0001140361-22-009255
CIK 0001305253other
Filed
Mar 10, 7:00 PM ET
Accepted
Mar 11, 9:06 PM ET
Size
6.7 KB
Accession
0001140361-22-009255
Insider Transaction Report
Form 4
Atkisson Erik
GC & Chief Compliance Officer
Transactions
- Award
Common Stock
2022-03-11+6,000→ 6,000 total - Award
Stock Option (Right to Buy)
2022-03-11+38,000→ 38,000 totalExercise: $5.10Exp: 2032-03-10→ Common Stock (38,000 underlying)
Footnotes (2)
- [F1]Represents shares underlying Restricted Stock Units award that will vest as to 33.3% on each of the first, second and third anniversaries of the grant date of March 11, 2022.
- [F2]The option vests in 48 equal monthly installments commencing on the grant date of March 11, 2022, subject to the Reporting Person's continuous service as of such date.
Documents
Issuer
Eiger BioPharmaceuticals, Inc.
CIK 0001305253
Entity typeother
Related Parties
1- filerCIK 0001885915
Filing Metadata
- Form type
- 4
- Filed
- Mar 10, 7:00 PM ET
- Accepted
- Mar 11, 9:06 PM ET
- Size
- 6.7 KB